Dear Reader,
As we approach the end of 2016, and publish our final issue of the American Journal of Cardiovascular Drugs for the year, we wish to reflect on another successful year for the journal and for others in the Adis Premier journals portfolio, and to thank all who have contributed to the American Journal of Cardiovascular Drugs over the past 12 months.
This year the American Journal of Cardiovascular Drugs published 41 manuscripts, including 23 review articles and 5 Adis Drug Evaluations, in 6 issues. The ten most popular articles published this year, based on the number of full-text downloads from Springer Link (as of October 2016), are listed below:
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Csaba András Dézsi
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
Jonathan Fialkow
Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
Antonio Carlos Pereira-Barretto
Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor
Jeanne Mendell, Hamim Zahir, Nobuko Matsushima, Robert Noveck, Frank Lee, Shuquan Chen, George Zhang, Minggao Shi
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial
Il Suk Sohn, Chong-Jin Kim, Byung-Hee Oh, Taek-Jong Hong, Chang-Gyu Park, Byung-Soo Kim, Woo-Baek Chung
A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach?
Carlos Brotons, Robert Benamouzig, Krzysztof J. Filipiak, Volker Limmroth, Claudio Borghi
Pharmacokinetics and Tolerability of the Novel Oral Prostacyclin IP Receptor Agonist Selexipag
Priska Kaufmann, Kaori Okubo, Shirin Bruderer, Tim Mant, Tetsuhiro Yamada, Jasper Dingemanse, Hideya Mukai
Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review
Luis Alcocer
Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation
Walid Saliba
Serelaxin: A Novel Therapy for Acute Heart Failure with a Range of Hemodynamic and Non-Hemodynamic Actions
Javier Diez
We offer our sincere thanks to all authors who have contributed articles to the American Journal of Cardiovascular Drugs over the course of 2016. Their skill and dedication are critical to the continued publication of the journal.
Mid-2016 saw the release of the ISI Journal Citation Reports and the latest journal impact factors. The Impact Factor of the American Journal of Cardiovascular Drugs fell marginally (~7%) from 2014 to 2.233, and the journal is currently ranked 61 of 124 journals in the ‘Cardiac & Cardiovascular System’ category. The majority of our other journals saw a rise in impact factor against the previous year. Most notably, five of our journals saw an increase of over 10% in impact factor—The Patient (17.08%), Clinical Drug Investigation (15.99%), the American Journal of Clinical Dermatology (13.17%), Drug Safety (13.52%), and Drugs (12.43%).
Another important milestone was reached for our recently launched open access journals, Drug Safety—Case Reports and Drugs—Real World Outcomes. Content from these journals is now available on PubMed Central.
The Adis journals portfolio will expand in 2017, with the launch of PharmacoEconomics—Open. This new journal will be fully open access and will focus on the publication of applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. It joins our other well respected health outcomes publications, PharmacoEconomics, Applied Health Economics and Health Policy, and The Patient: Patient-Centered Outcomes Research.
The quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for the American Journal of Cardiovascular Drugs in the last 12 months:
Shiv K. Agarwal, USA
Vineet Ahuja, India
Lorenzo Alberio, Switzerland
Muaamar Al-Gobari, Switzerland
Dominick J. Angiolillo, USA
Anastasia L. Armbruster, USA
Wilbert S. Aronow, USA
Christian Asseburg, Sweden
Vasilios G. Athyros, Greece
Ekaterina V. Baranova, the Netherlands
Anthony A. Bavry, USA
Barbara A. Bentz, USA
Aleš Blinc, Slovenia
Dirk J. Blom, South Africa
Edimar A. Bocchi, Brazil
Barry A. Borlaug, USA
Kenneth M. Borow, USA
Sorin J. Brener, USA
Sebastiano Calandra, Italy
Bertrand Cariou, France
Mattias Carlstrom, Sweden
Guillaume Cayla, France
Wisit Cheungpasitporn, USA
Derek P.B. Chew, Australia
Chern-En Chiang, Taiwan
Gabriel Chodick, Israel
Jonathan D. Cicci, USA
Arrigo F.G. Cicero, Italy
Andrea Colli, Italy
James M. Cotton, UK
Bertrand Crozatier, France
Wei Cui, China
Timothy W. Cutler, USA
Michael H. Davidson, USA
Olivier S. Descamps, Belgium
Sandeep Devabhakthuni, USA
Thomas Dschietzig, Germany
Andre R. Duraes, Brazil
Martin H. Ellis, Israel
Phillip Erwin, USA
Jonathan Fialkow, USA
Sebastien Foulquier, the Netherlands
Lutz Frankenstein, Germany
Freja S. Gaborit, Denmark
Thomas D. Giles, USA
Ornella Guardamagna, Italy
Job Harenberg, Germany
Derek J. Hausenloy, Singapore
Timothy D. Henry, USA
Inmaculada Hernandez, USA
Daniel E. Hilleman, USA
Hirofumi Hioki, Japan
Patrick Honoré, Belgium
Enyu Imai, Japan
Simon Jones, UK
Peter G. Jørgensen, Denmark
Parijat S. Joy, USA
Jayant K. Kairi, India
Waasil Kareem, USA
Swapna U. Karkare, USA
Lucas M. Kimmig, USA
Sverre E. Kjeldsen, Norway
Gerhard M. Kostner, Austria
David M. Kwiatkowski, USA
Irene M. Lang, Austria
Peter Lansberg, the Netherlands
Francesco Lapi, Italy
Kwan S. Lee, USA
Chung-Yi Li, Taiwan
Jian-Jun Li, China
Danny Liew, Australia
Tsung-Hua Lin, USA
Jou-Wei Lin, Taiwan
Charles E. Mahan, USA
Ahmed N. Mahmoud, USA
Arduino A. Mangoni, Australia
Jacques Mansourati, France
Maurizio Margaglione, Italy
Pedro Marques da Silva, Portugal
Carlos Martinez, Germany
Luca Mascitelli, Italy
Richard P. Mason, USA
John A. McClung, USA
Marco Metra, Italy
Toru Miyoshi, Japan
Ajit S. Mullasari, India
Sajan J.S. Nagpal, USA
Eliano P. Navarese, Italy
Wilmer W. Nichols, USA
Barbara Nussbaumer, Austria
Leiv Ose, Norway
Marlies Ostermann, UK
Siva K. Panguluri, USA
Előd Papp, Hungary
Akhil Parashar, USA
Alan R. Parrish, USA
Nishith N. Patel, UK
Paola Patrignani, Italy
Gregory M. Peterson, Australia
Mario Petretta, Italy
Sven Poli, Germany
Daniel J. Quinlan, UK
Yogesh N. Reddy, USA
Zeljko Reiner, Croatia
Anna Remková, Slovakia
Janine E. Roeters van Lennep, the Netherlands
Leonardo Roever, Brazil
Emilio Ros, Spain
Giuseppe M.C. Rosano, UK
Eli M. Roth, USA
Francois Roubille, France
Lewis J. Rubin, USA
Filippo M. Sarullo, Italy
Jennifer Simon, USA
Olivier Sitbon, France
Pil Sang S. Song, Republic of Korea
Geraud Souteyrand, France
Alessandro Squizzato, Italy
Isao Taguchi, Japan
Jose E. Tanus-Santos, USA
Costas G. Thomopoulos, Greece
Nidhish Tiwari, USA
Jay H. Traverse, USA
Bruno Trimarco, Italy
Kenichi Tsujita, Japan
Kengo Tsukahara, Japan
Per O. Vandvik, Norway
Monica Verdoia, Italy
Francesco Violi, Italy
Joan Vlayen, Belgium
Bernard Vrijens, Belgium
Amy Z. Wang, USA
Amanda Wang, Australia
Ralph-Steven Wedemeyer, Germany
Robert B. Wilson, Australia
James M. Wright, Canada
Yong Zhan, USA
Zugui Zhang, USA
Xin-Lin Zhang, China
In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
A. Michael Lincoff, USA [Consulting Editor]
Balram Bhargava, India
Deepak L. Bhatt, USA
John P. Cooke, USA
Prakash C. Deedwania, USA
Naranjan S. Dhalla, Canada
Phillip Erwin, USA
Arthur M. Feldman, USA
Valentin V. Fuster, USA
Xavier Girerd, France
Sidney Goldstein, USA
Joseph A. Hill, USA
Gowraganahalli Jagadeesh, USA
Neal S. Kleiman, USA
Antoine Lafont, France
Thierry H. Le Jemtel, USA
Frans H.H. Leenen, Canada
Mario Marzilli, Italy
Venu Menon, USA
Gilles Montalescot, France
Stephen J. Nicholls, Australia
Ali Oto, Turkey
Bertram Pitt, USA
Silvia G. Priori, Italy
C. Venkata S. Ram, USA
Gianpaolo Reboldi, Italy
Johanne Silvain, France
Kewal K. Talwar, India
Michal Tendera, Poland
Udho Thadani, USA
Alec Vahanian, France
George W. Vetrovec, USA
Michael A. Weber, USA
William S. Weintraub, USA
Harvey D. White, New Zealand
Nathan D. Wong, USA
We hope that you have found the articles published throughout 2016 to be both interesting and informative. We have appreciated the high quality of content contributed to the journal this year and we look forward to keeping you up to date with topical issues in the field of cardiovascular therapeutics in 2017.
With best wishes,
Amitabh Prakash
Editor, American Journal of Cardiovascular Drugs
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Am J Cardiovasc Drugs 17, 1–4 (2017). https://doi.org/10.1007/s40256-016-0207-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40256-016-0207-y